<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments

Wound Care

A Turbulent Year: Q420/FY20 AWC Market Recap

A year of turbulence as COVID-19 affects the WW Advanced Wound Care market at different times and in a v...

Wound Care

Weakened by COVID: Q420/FY20 Infection Prevention - US Vascular Access Adjunct Market

Anticipated growth for Q4 was weakened by a resurgence of COVID-19 and was not enough to sustain growth ...

Wound Care

Mediq: Execution of Strategy Through Acquisitions

Ragna Ouwerkerk, PR Manager at Mediq, discusses the Company and its recent acquisitions in an interview ...

Wound Care

Breast & Hernia Procedures Stall: Q420/FY20 US Surgical Matrices Market Recap

The recovery in breast and hernia procedure stalled in Q420, with revenue dropping -9.2% YoY, according ...

Wound Care

R&D Focus: Patents, Products & Predictions: The Week in Wound Care

Facing the prevailing headwinds of the pandemic, the MedTech industry presses on with product innovation...

Wound Care

The Impact of COVID-19 on US Advanced Wound Care: An Update

SmartTRAK analyzes how COVID-19 and vaccinations will impact the US Advanced Wound Care Market in 2021. ...

Wound Care

High CEO Turnover and Succession Rate in Wound Care

SmartTRAK reviews the impact and underlying reasons behind the high turnover rate among CEOs in the woun...

Wound Care

EWMA 2020 Virtual Meeting Highlights and The Impact of COVID-19 on Wound Care

SmartTRAK reviews the 2020 Virtual EWMA meeting covering the impact of COVID-19, the growing use of digi...

Wound Care

Europe: New Routines in Greetings and in Wound Management

SmartTRAK examines the Top 5 countries in Europe during the time of COVID-19 and estimates how the Advan...

Wound Care

Gain vs Loss: Q320 Infection Prevention: US Vascular Access Adjunct Market

Q3 makes a recovery from Q220 losses but gains remain below pre-COVID levels For Q320, according to BioM...

1
...
11 12 13
...
24